515 filings
Page 2 of 26
424B3
avyhyd8vviqzdb561e
14 Aug 20
Prospectus supplement
5:22pm
424B3
qhfuv 30tporf6z
31 Jul 20
Prospectus supplement
12:00am
EFFECT
ktuk9wmcm8u3wd luzy
29 Jul 20
Notice of effectiveness
12:15am
CORRESP
8a7p0 byfm
24 Jul 20
Correspondence with SEC
12:00am
D/A
hqvjqknc0oe sxo
23 Jul 20
Indefinite amount in debt / Debt convertible into equity., sold $5.61M, 18 investors
5:00pm
UPLOAD
8afm0gj
22 Jul 20
Letter from SEC
12:00am
8-K
w7pvhh7op0pi vngpet
9 Jul 20
Entry into a Material Definitive Agreement
4:16pm
8-K
3yw85qo9n pnj4a0
23 Jun 20
Entry into a Material Definitive Agreement
5:00pm
8-K
vid1f 4yafbxt
19 Jun 20
Entry into a Material Definitive Agreement
4:15pm
D
e9xz t70x
12 Jun 20
Indefinite amount in debt / Debt convertible into equity, sold $2.42M, 9 investors
4:46pm
SC 13G
bc497mag7318l vpf
10 Jun 20
GT Biopharma / BRISTOL INVESTMENT FUND ownership change
8:08am
4
84h5ryv 6q3h29hx
4 Jun 20
GT Biopharma / Tony Cataldo ownership change
5:15pm
8-K
jsx3e7 w30scczx
29 May 20
Regulation FD Disclosure
4:15pm
SC 13G/A
pl7kvh
18 May 20
GT Biopharma / BRISTOL INVESTMENT FUND ownership change
4:06pm
4
xh1 fk33s
14 May 20
GT Biopharma / Steven W Weldon ownership change
1:40pm